News & Events

• November 16, 2023
  

  C-Path’s Translational Therapeutics Accelerator: A Unique Solution to Successfully Bridge the Valley of Death in Academic Drug Discovery and Development

• November 15, 2023
  

  Transplant Therapeutics Consortium Impact on Drug Development

• August 9, 2023
  

  C-Path’s Duchenne Regulatory Science Consortium and Duchenne Data Foundation Announce Collaboration to Advance Solutions for Duchenne Muscular Dystrophy

  TUCSON, Ariz. and VEENENDAAL, Netherlands, August 9, 2023 — Critical Path Institute’s (C-Path) Duchenne Regulatory Science Consortium (D-RSC) and the Duchenne Data Foundation (DDF) are excited to announce a joint collaboration aimed at advancing research and improving healthcare for individuals with Duchenne muscular dystrophy (DMD) and other dystrophinopathies (conditions linked to mutations in the DMD......
• August 4, 2023
  

  Clinical Outcome Assessments: Does one size fit all?

  This webinar is presented jointly by the Rare Disease COA Consortium and C-Path’s Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP), and was held April 27, 2023. View the recording below....
• July 6, 2023
  

  Worldwide collaborative framework for optimizing new Parkinson’s treatment trials with patient centric outcome measures